An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Geneva”.
The original version of this article has been updated.
. 2023 Apr 4;13:1187021. doi: 10.3389/fonc.2023.1187021
Erratum: The landscape of immunotherapy resistance in NSCLC
Frontiers Production Office1,*
1
Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
This article was submitted to Thoracic Oncology, a section of the journal Frontiers in Oncology
Received 2023 Mar 15; Accepted 2023 Mar 15; Collection date 2023.
Keywords: immunotherapy, resistance, checkpoint inhibitor, NSCLC, lung cancer
Copyright © 2023 Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC10111005 PMID: 37081979
This corrects the article "The Landscape of Immunotherapy Resistance in NSCLC" in volume 12, 817548.